MedTrace Logo

Pharmacist-led Medicines Management Outpatient Service

NCT01534559 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2019-03-25

No results posted yet for this study

Summary

It widely accepted that a number of medication related problems can occur after the patient has been discharged from the hospital. An obvious extension of the ongoing integrated medicines management programme (IMMP) is therefore to provide a medicines management clinic within an outpatient setting as well as follow-up telephone calls from a clinical pharmacist. This study aims to assess the influence a pharmacist-led medicines management outpatient service on patients at high risk of medication related problems.

It is anticipated that this service will

* Ensure continuity of pharmaceutical care for patients post discharge.
* Reinforce patient education in order to improve knowledge and understanding of the medication prescribed.
* Ensure that both prescription medicines and OTC preparations are used appropriately.
* Facilitate the communication with other members of healthcare team in order to agree and implement measures to overcome medication related problems.

Conditions

  • Patients at High Risk of Medicine-related Problems

Interventions

OTHER

Medicines Management Outpatient service

New customised clinical pharmacy service (medicines management clinic and follow-up phone calls)

Sponsors & Collaborators

  • Queen's University, Belfast

    lead OTHER

Principal Investigators

  • James C McElnay, BSc, PhD · Queen's University, Belfast

  • Michael G Scott, BSc, PhD · Northern Health and Social Care Trust

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2017-12-31
Completion
2018-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01534559 on ClinicalTrials.gov